Further to the Board meeting outcome dated August 12, 2025, in relation to the consideration and approval of Unaudited Financial Results of Elitecon International limited ('the Company') ....
ELITECON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Elitecon International Limited (BSE: 539533) filed its investor presentation for Q1 FY2026 (quarter ended June 30, 2025) following the August 12, 2025 board meeting. On a standalone basis, sales jumped 302% year-on-year to INR 199.23 crore, with EBITDA up 325% to INR 20.93 crore and PAT up 350% to INR 20.41 crore. On a consolidated basis, revenue rose 68% quarter-on-quarter to INR 524.87 crore, with EBITDA at INR 73.37 crore and PAT at INR 72.08 crore. The company, a tobacco and FMCG exporter to 50+ countries with 80 million cigarette sticks per month capacity, also highlighted an INR 300 crore QIP fundraise approved on August 1, 2025, aimed at acquiring FMCG companies through its wholly owned subsidiary. Management described the quarter as 'exceptional momentum' setting a 'powerful growth trajectory' for the rest of FY2026, backed by plans for capacity expansion, product innovation, and deeper penetration into EU, MENA, and ASEAN markets.
Strong triple-digit growth and INR 300 crore fundraise signal aggressive expansion plans, but the equity dilution from the QIP could weigh on existing shareholders in the near term. The presentation hints at continued growth momentum, potentially supporting positive sentiment on the stock.